Frontier Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,076
Closed -$214K 282
2023
Q3
$214K Sell
1,076
-43
-4% -$10.2K ﹤0.01% 266
2023
Q2
$319K Sell
1,119
-558
-33% -$155K ﹤0.01% 256
2023
Q1
$364K Sell
1,677
-12,806
-88% -$2.5M ﹤0.01% 255
2022
Q4
$2.98M Buy
14,483
+13,484
+1,350% +$3.41M 0.03% 246
2022
Q3
$278K Sell
999
-11,229
-92% -$2.86M ﹤0.01% 268
2022
Q2
$2.34M Sell
12,228
-77,537
-86% -$13.7M 0.03% 265
2022
Q1
$18.6M Buy
+89,765
New +$14.8M 0.17% 173

Other funds holding SWAV

Frontier Capital Management's SWAV Position: Q4 2023 in Review

Frontier Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 1,076 shares — an estimated $214K sold.

Frontier Capital Management first reported a position in SWAV in Q1 2022 and held it in 7 quarters. The position peaked at $18.6M in Q1 2022. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

  • Frontier Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Frontier Capital Management sold 1,076 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $214K.
  • Frontier Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • Frontier Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $18.6M in Q1 2022.
  • 427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Frontier Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.